X
Axabin

Axabin (Rivaroxaban)

  • Generic name: Rivaroxaban
  • Pharmacologic Category: Anticoagulant
  • Dosage Forms: Tablet, Oral (10 mg, 15 mg, 20 mg)
  • Mechanism of Action: A direct, selective inhibitor of Factor Xa
  • Indications
  • Benefits of Axabin
  • Contraindications
  • Reduce risk of stroke and systemic embolism in nonvalvular atrial fibrillation (NVAF)
  • Treatment of deep vein thrombosis (DVT)
  • Treatment of pulmonary embolism (PE)
  • Reduction in the risk of recurrence of DVT or PE
  • Prophylaxis of DVT, which may lead to PE in patients undergoing knee or hip replacement surgery
  • Prophylaxis of venous thromboembolism (VTE) in acutely ill medical patients
  • New generation of anticoagulants
  • No routine coagulation monitoring required (INR test)
  • Fewer drug-drug interactions
  • No food – drug interactions
  • Axabin is taken once a day. (The dose is determined based on the patient's creatinine clearance.)
  • No frequent dose adjustment based on age, sex and weight
  • Pregnancy and Breast-Feeding
  • severe hepatic impairment
  • Serious hypersensitivity to Axabin or any component of the formulation
  • Severe and active bleeding
  • Patients who are under 18 years’ old

Axabin is a prescription medicine used to:

reduce the risk of stroke and blood clots in people who have a medical condition called atrial fibrillation that is not caused by a heart valve problem. With atrial fibrillation, part of the heart does not beat the way it should. This can lead to the formation of blood clots, which can travel to the brain, causing a stroke, or to other parts of the body

treat blood clots in the veins of your legs (deep vein thrombosis or DVT) or lungs (pulmonary embolism or PE)
reduce the risk of blood clots happening again in people who continue to be at risk for DVT or PE after receiving treatment for blood clots for at least 6 months
help prevent a blood clot in the legs and lungs of people who have just had hip or knee replacement surgery
help prevent blood clots in certain people hospitalized for an acute illness and after discharge, who are at risk of getting blood clots because of the loss of or decreased ability to move around (mobility) and other risks for getting blood clots, and who do not have a high risk of bleeding

 

Axabin is used with low dose aspirin to:

reduce the risk of serious heart problems, heart attack and stroke in people with coronary artery disease (a condition where the blood supply to the heart is reduced or blocked) or peripheral artery disease (a condition where the blood flow to the legs is reduced)

 

Did you know, if you have AFib not caused by a heart valve problem, you are 5x more likely to have a stroke

Did you know…

Do you know, how many VTE attack occurred in the world annually?

Estimated VTE attack rates (including incident and recurrent VTE) range from 142 to >300 per 100,000 person-years. Estimated attack rates for DVT and PE are 91–255 and 51–75 per 100,000 person-years, respectively.

SPECIFIC ADVANTAGES:

  • Easy oral administration
  • Once daily dosing
  • No requirement for routine coagulation monitoring
  • Demonstrated benefits across different indications
  • Lower adverse effects
  • No dietary restrictions
  • Lower Drug-Drug Interactions
  • Rapid action
  • Without risk of HIT

Contact Us

Telegram
@Anticoagulation_Therapy
.
medinfo@arenalifescience.com
.
(+98) 910 587 77 17
دی ان ان